Close Menu
Daily Guardian
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
What's On

Sigenergy Advances Its European C&I and Utility-Scale Storage Strategy at Sigenergy Day Europe 2026

September 19, 2026

Canada’s defence minister calls U.S. deal on Greenland ‘encouraging’

September 19, 2026

Silly Nice and stupidDOPE Launch “THE RECORD,” a Cannabis Justice Editorial Campaign Built to Move From Screens to the Streets of New York City

September 19, 2026

Flight training school says 2 killed in plane crash near Kisbey, Sask.

September 19, 2026

Carney and Macron to meet in Saint-Pierre-et-Miquelon on Sunday

September 19, 2026
Facebook X (Twitter) Instagram
Finance Pro
Facebook X (Twitter) Instagram
Daily Guardian
Subscribe
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
Daily Guardian
Home » $4.396 Bn Glycomics Market Trends, Opportunities, and Forecasts, 2030 – Rising Chronic and Infectious Disease Burden and Demand for Advanced Diagnostic and Therapeutic Tools
Press Release

$4.396 Bn Glycomics Market Trends, Opportunities, and Forecasts, 2030 – Rising Chronic and Infectious Disease Burden and Demand for Advanced Diagnostic and Therapeutic Tools

By News RoomDecember 2, 20253 Mins Read
.396 Bn Glycomics Market Trends, Opportunities, and Forecasts, 2030 – Rising Chronic and Infectious Disease Burden and Demand for Advanced Diagnostic and Therapeutic Tools
Share
Facebook Twitter LinkedIn Pinterest Email

Dublin, Dec. 02, 2025 (GLOBE NEWSWIRE) — The “Glycomics Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F” report has been added to ResearchAndMarkets.com’s offering.

The Global Glycomics Market, valued at USD 1.94 Billion in 2024, is projected to experience a CAGR of 14.59% to reach USD 4.39 Billion by 2030

Glycomics is defined as the comprehensive study of glycomes, encompassing all glycan structures, whether free or complex molecules, within an organism or cell, to understand their genetic, physiological, and pathological aspects. The global glycomics market growth is significantly driven by the increasing prevalence of chronic diseases, necessitating advanced diagnostic and therapeutic tools.

The escalating global burden of chronic and infectious diseases significantly propels the glycomics market, as glycans are integral to disease pathology, immune modulation, and pathogen interactions, necessitating advanced diagnostic and therapeutic tools. Conditions such as cancer, autoimmune disorders, and metabolic diseases, including diabetes, demand sophisticated glycomics-based solutions for early detection and targeted interventions.

According to the International Diabetes Federation, in 2023, an estimated 537 million adults aged 20-79 years were living with diabetes worldwide, underscoring the substantial patient population requiring improved approaches to disease management. This pervasive disease prevalence directly stimulates demand for glycomics research and applications, fostering the discovery of novel glycan biomarkers and the development of targeted glycan-based drugs and vaccines to address critical unmet medical needs.

Key Market Challenges

A significant challenge impeding market expansion stems from the inherent structural complexity and vast diversity of glycan structures. This biological intricacy profoundly complicates comprehensive analysis and standardization efforts essential for advancing glycomics applications. The extensive range of glycan configurations and their context-dependent roles necessitate highly specialized and often costly analytical techniques, leading to prolonged research and development cycles.

Key Market Trends

The integration of artificial intelligence and machine learning in glycan data analysis represents a transformative trend, enabling researchers to process and interpret the vast, complex datasets generated from glycomics studies with greater efficiency and accuracy. These technologies are crucial for identifying patterns and correlations in glycan structures that were previously challenging to detect.

For example, according to GlycanML: A Multi-Task and Multi-Structure Benchmark for Glycan Machine Learning, published on arXiv in May 2024, machine learning models are being developed to predict glycan taxonomy, immunogenicity, glycosylation types, and protein-glycan interactions across diverse tasks. This analytical capability accelerates biomarker discovery and therapeutic development by translating complex glycomics information into actionable insights.

Key Attributes:

Report Attribute Details
No. of Pages 186
Forecast Period 2024 – 2030
Estimated Market Value (USD) in 2024 $1.94 Billion
Forecasted Market Value (USD) by 2030 $4.39 Billion
Compound Annual Growth Rate 14.5%
Regions Covered Global


Report Scope:

Key Market Players Profiled:

  • Thermo Fisher Scientific, Inc.
  • Merck KgaA
  • Agilent Technologies Inc.
  • Bruker Corporation
  • New England Biolabs Inc.
  • Shimadzu Corporation
  • Waters Corporation
  • Takara Bio USA Inc
  • Asparia Glycomics
  • RayBiotech Life, Inc.

By Product:

  • Enzymes
  • Kits
  • Reagents
  • Instruments

By Application:

  • Drug Discovery & Development
  • Diagnostics
  • Others

By End Use:

  • Academic & Research Institutes
  • Pharmaceutical & Biotechnology Companies
  • Biopharmaceutical Companies
  • CROs

By Region:

  • North America
  • Europe
  • Asia-Pacific
  • South America
  • Middle East & Africa

For more information about this report visit https://www.researchandmarkets.com/r/qinj1t

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.


Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

Sigenergy Advances Its European C&I and Utility-Scale Storage Strategy at Sigenergy Day Europe 2026

Silly Nice and stupidDOPE Launch “THE RECORD,” a Cannabis Justice Editorial Campaign Built to Move From Screens to the Streets of New York City

Prior Authorization Under CMS-0057-F: How Payers Are Rebuilding Utilization Management for Compressed Timelines

Crypto News: New Crypto Pepeto Announces Full Platform Completion While Solana Price Prediction Targets $1,000

Crypto News: Remittix Less Than $65K Away From $32M Launch Reveal as XRP Price Prediction Targets Powerful Recovery

Attorney Nick Abaza Celebrates 25 Years of Exemplary Legal Practice

Sixthfin UK Financial Close Management Software Evaluation Criteria Released as Multi-ERP Control, Account Justification and Audit Evidence Enter 2026 Vendor Scorecards

New Crypto: Remittix Targets a $0.50 Launch While the Ethereum Price Prediction Points Toward $6,000

New Crypto Pepeto Announces Binance-Veteran Developer Appointment With Three Products Live And Ethereum Price Prediction Targets $6,000

Editors Picks

Canada’s defence minister calls U.S. deal on Greenland ‘encouraging’

September 19, 2026

Silly Nice and stupidDOPE Launch “THE RECORD,” a Cannabis Justice Editorial Campaign Built to Move From Screens to the Streets of New York City

September 19, 2026

Flight training school says 2 killed in plane crash near Kisbey, Sask.

September 19, 2026

Carney and Macron to meet in Saint-Pierre-et-Miquelon on Sunday

September 19, 2026

Latest News

Meta’s Muse is creepy, but maybe not for the reasons you think

September 19, 2026

‘Why walk away?’: Emotional Danielle Smith speaks against separation at online forum

September 19, 2026

Prior Authorization Under CMS-0057-F: How Payers Are Rebuilding Utilization Management for Compressed Timelines

September 19, 2026
Facebook X (Twitter) Pinterest TikTok Instagram
© 2026 Daily Guardian Canada. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.

Go to mobile version